Glia: initiators and progressors of pathology in Parkinson's disease

GM Halliday, CH Stevens - Movement Disorders, 2011 - Wiley Online Library
Background: Glia are traditionally known as support cells for neurons, and their role in
neurodegeneration has been largely considered secondary to neuronal dysfunction. We …

Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts

L Fellner, KA Jellinger, GK Wenning, N Stefanova - Acta neuropathologica, 2011 - Springer
Abstract Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system
atrophy (MSA) are adult onset neurodegenerative disorders characterised by prominent …

α-Synuclein alters toll-like receptor expression

D Béraud, M Twomey, B Bloom, A Mittereder… - Frontiers in …, 2011 - frontiersin.org
Parkinson's disease, an age-related neurodegenerative disorder, is characterized by the
loss of dopamine neurons in the substantia nigra, the accumulation of α-synuclein in Lewy …

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

Y Couch, L Alvarez-Erviti, NR Sibson… - Journal of …, 2011 - Springer
Background Activated microglia are a feature of the host response to neurodegeneration in
Parkinson's disease (PD) and are thought to contribute to disease progression. Recent …

Expression of mutant alpha-synuclein modulates microglial phenotype in vitro

L Rojanathammanee, EJ Murphy… - Journal of …, 2011 - Springer
Background Increased reactive microglia are a histological characteristic of Parkinson's
disease (PD) brains, positively correlating with levels of deposited α-synuclein protein. This …

Parkinson's disease mouse models in translational research

PMA Antony, NJ Diederich, R Balling - Mammalian Genome, 2011 - Springer
Animal models with high predictive power are a prerequisite for translational research. The
closer the similarity of a model to Parkinson's disease (PD), the higher is the predictive value …

Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases

C Gibrat, F Cicchetti - Progress in Neuro-Psychopharmacology and …, 2011 - Elsevier
Neurodegenerative disorders are a subset of disabling pathologies characterized, in part, by
a progressive and specific loss of certain brain cell populations. Current therapeutic …

The executioners sing a new song: killer caspases activate microglia

JL Venero, MA Burguillos, P Brundin… - Cell Death & …, 2011 - nature.com
Activation of microglia and inflammation-mediated neurotoxicity are suggested to have key
roles in the pathogenesis of several neurodegenerative disorders. We recently published an …

α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease

JP Covy, BI Giasson - Neurotoxicology, 2011 - Elsevier
Parkinson disease (PD) is the most common movement disorder. It is characterized by
bradykinesia, postural instability, resting tremor, and rigidity associated with the progressive …

Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36

NA Abumrad, DJ Moore - The Journal of Clinical …, 2011 - Am Soc Clin Investig
Parkinson disease (PD) is a relatively common neurodegenerative disorder characterized
by the progressive degeneration of dopaminergic neurons in the substantia nigra. About 5 …